Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients
Coronavirus disease 2019 (COVID-19) was first reported in late December 2019 in Wuhan, China. The etiological agent of this disease is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the high transmissibility of the virus led to its rapid global spread and a major pandemic (ongoing...
Main Authors: | Nayara Azinheira Nobrega Cruz, Lilian Caroline Gonçalves de Oliveira, Helio Tedesco Silva Junior, Jose Osmar Medina Pestana, Dulce Elena Casarini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2021.700220/full |
Similar Items
-
Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy
by: Lilian Caroline Gonçalves Oliveira, et al.
Published: (2021-12-01) -
Reminiscences of Ervin G Erdös
by: Igić Rajko
Published: (2019-01-01) -
The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01) -
Renin-angiotensin system in the pathogenesis of COVID-19 and possible drug targets
by: Sujay Halkur Shankar, et al.
Published: (2021-01-01) -
SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants
by: Filippo Scialo, et al.
Published: (2021-05-01)